BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1064 related articles for article (PubMed ID: 10768595)

  • 1. Renal cell carcinoma: presentation, staging, and surgical treatment.
    Russo P
    Semin Oncol; 2000 Apr; 27(2):160-76. PubMed ID: 10768595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing concepts in the surgical management of renal cell carcinoma.
    Lam JS; Shvarts O; Pantuck AJ
    Eur Urol; 2004 Jun; 45(6):692-705. PubMed ID: 15149740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and surgical management of renal cell carcinoma with inferior vena cava tumor thrombus--a report of 6 cases with literature review].
    Li XD; Cheng S; Rui XF; Li GH; Chen YB; Yu DM
    Ai Zheng; 2005 Nov; 24(11):1394-7. PubMed ID: 16552970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconsidering the necessity of ipsilateral adrenalectomy during radical nephrectomy for renal cell carcinoma.
    Leibovitch I; Raviv G; Mor Y; Nativ O; Goldwasser B
    Urology; 1995 Sep; 46(3):316-20. PubMed ID: 7660505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of pancreatic metastasis from renal cell carcinoma].
    Chi TY; Sang XT; Mao YL; Yang ZY; Lu X; Zhong SX; Huang JF
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):793-6. PubMed ID: 19173818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of renal cell carcinoma with vena cava tumor thrombi].
    Li XF; Zhou FJ; Qiu SP; Liu ZW; Wu RP; Huang K; Mei H
    Ai Zheng; 2004 Sep; 23(9):1074-6. PubMed ID: 15363205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of von Hippel-Lindau disease with renal involvement].
    Chrétien Y; Chauveau D; Richard S; Droz D; Correas JM; Mejean A; Dufour B; Grünfeld JP
    Prog Urol; 1997 Dec; 7(6):939-47. PubMed ID: 9490138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single center preliminary experience with hand-assisted laparoscopic resection of isolated renal cell carcinoma fossa recurrences.
    Bandi G; Wen CC; Moon TD; Nakada SY
    Urology; 2008 Mar; 71(3):495-9; discussion 499-500. PubMed ID: 18342195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the indications for laparoscopic radical nephrectomy.
    Mattar K; Finelli A
    Curr Opin Urol; 2007 Mar; 17(2):88-92. PubMed ID: 17285016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real indications for adrenalectomy in renal cell carcinoma.
    Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
    Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is ipsilateral adrenalectomy a necessary component of radical nephrectomy?
    Shalev M; Cipolla B; Guille F; Staerman F; Lobel B
    J Urol; 1995 May; 153(5):1415-7. PubMed ID: 7714954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of renal cell carcinoma.
    Hilton S
    Semin Oncol; 2000 Apr; 27(2):150-9. PubMed ID: 10768594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal masses: urologic management.
    Ornstein DK; Arcangeli CG; Andriole GL
    Magn Reson Imaging Clin N Am; 1997 Feb; 5(1):1-12. PubMed ID: 8995121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conservative surgery for renal carcinoma].
    González Martín M; Alvarez Castelo LM; Chantada Abal V; Rodríguez-Rivera J; Sánchez Merino JM; Gómez Veiga F
    Actas Urol Esp; 1999 May; 23(5):424-31. PubMed ID: 10427817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease.
    Ploussard G; Droupy S; Ferlicot S; Ples R; Rocher L; Richard S; Benoit G
    Urology; 2007 Sep; 70(3):435-9. PubMed ID: 17905091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.